Ambea AB (publ) (STO:AMBEA)
Sweden · Delayed Price · Currency is SEK 145.70
+11.00 (8.17%)
May 7, 2026, 5:29 PM CET
Ambea AB Market Cap
Ambea AB has a market cap or net worth of 11.06 billion as of May 7, 2026. Its market cap has increased by 18.18% in one year.
Market Cap
11.06B
Enterprise Value
23.57B
Revenue
16.11B
Ranking
n/a
PE Ratio
17.01
Stock Price
145.70
Market Cap Chart
Since March 31, 2017, Ambea AB's market cap has increased from 5.58B to 11.06B, an increase of 98.25%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 11.06B | -6.94% |
| Dec 30, 2025 | 11.88B | 46.78% |
| Dec 30, 2024 | 8.10B | 71.86% |
| Dec 29, 2023 | 4.71B | 13.21% |
| Dec 30, 2022 | 4.16B | -27.18% |
| Dec 30, 2021 | 5.71B | -7.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.52B |
| Getinge AB | 51.04B |
| Sectra AB | 50.29B |
| Camurus AB | 32.56B |
| Attendo AB | 14.96B |
| Vitrolife AB | 14.63B |
| Nolato AB | 13.28B |
| BioGaia AB | 12.15B |